|
NVDA
|
Technology |
Rosenblatt |
Maintains
|
Buy
→
Buy
|
—
|
$5.4T
|
$19.82
|
+0.9%
|
+2.3%
|
+1.8%
|
-1.3%
|
-0.3%
|
-1.8%
|
|
LLY
|
Healthcare |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$917.2B
|
$255.99
|
+0.0%
|
+2.5%
|
+0.7%
|
-0.3%
|
+1.4%
|
+0.9%
|
|
LLY
|
Healthcare |
Mizuho |
Maintains
|
Buy
→
Buy
|
—
|
$917.2B
|
$255.99
|
+0.0%
|
+2.5%
|
+0.7%
|
-0.3%
|
+1.4%
|
+0.9%
|
|
CVX
|
Energy |
DZ Bank |
Downgrade
|
Buy
→
Hold
|
—
|
$366.1B
|
$102.60
|
-2.1%
|
-2.2%
|
+0.9%
|
+0.7%
|
-1.7%
|
+1.8%
|
|
BABA
|
Consumer Cyclical |
Benchmark |
Maintains
|
Buy
→
Buy
|
—
|
$324.7B
|
$197.38
|
+0.1%
|
+1.7%
|
-0.7%
|
-1.5%
|
-0.6%
|
+0.2%
|
|
BABA
|
Consumer Cyclical |
UBS |
Maintains
|
Market Perform
→
Market Perform
|
—
|
$324.7B
|
$197.38
|
+0.1%
|
+1.7%
|
-0.7%
|
-1.5%
|
-0.6%
|
+0.2%
|
|
BABA
|
Consumer Cyclical |
CLSA |
Maintains
|
Buy
→
Buy
|
—
|
$324.7B
|
$197.38
|
+0.1%
|
+1.7%
|
-0.7%
|
-1.5%
|
-0.6%
|
+0.2%
|
|
BABA
|
Consumer Cyclical |
Citigroup |
Maintains
|
Buy
→
Buy
|
—
|
$324.7B
|
$197.38
|
+0.1%
|
+1.7%
|
-0.7%
|
-1.5%
|
-0.6%
|
+0.2%
|
|
BABA
|
Consumer Cyclical |
HSBC |
Maintains
|
Buy
→
Buy
|
—
|
$324.7B
|
$197.38
|
+0.1%
|
+1.7%
|
-0.7%
|
-1.5%
|
-0.6%
|
+0.2%
|
|
BABA
|
Consumer Cyclical |
Oppenheimer |
Maintains
|
Outperform
→
Outperform
|
—
|
$324.7B
|
$197.38
|
+0.1%
|
+1.7%
|
-0.7%
|
-1.5%
|
-0.6%
|
+0.2%
|
|
BABA
|
Consumer Cyclical |
KeyBanc Capital Markets |
Maintains
|
Overweight
→
Overweight
|
—
|
$324.7B
|
$197.38
|
+0.1%
|
+1.7%
|
-0.7%
|
-1.5%
|
-0.6%
|
+0.2%
|
|
BABA
|
Consumer Cyclical |
Mizuho |
Maintains
|
Buy
→
Buy
|
—
|
$324.7B
|
$197.38
|
+0.1%
|
+1.7%
|
-0.7%
|
-1.5%
|
-0.6%
|
+0.2%
|
|
AMGN
|
Healthcare |
SVB Leerink |
Maintains
|
Market Perform
→
Market Perform
|
—
|
$179.7B
|
$244.08
|
-2.3%
|
-6.5%
|
+2.5%
|
-1.6%
|
-1.0%
|
+0.0%
|
|
ANET
|
Technology |
Argus |
Maintains
|
Buy
→
Buy
|
—
|
$179.2B
|
$23.70
|
+0.1%
|
+0.8%
|
-0.4%
|
-0.8%
|
-0.6%
|
-1.0%
|
|
TMO
|
Healthcare |
Argus |
Maintains
|
Buy
→
Buy
|
—
|
$168.8B
|
$536.99
|
+0.4%
|
+0.4%
|
+0.6%
|
-0.8%
|
+0.6%
|
-0.1%
|
|
MRVL
|
Technology |
Credit Suisse |
Maintains
|
Outperform
→
Outperform
|
—
|
$153.3B
|
$61.34
|
+0.3%
|
+0.9%
|
-1.4%
|
-0.8%
|
-0.1%
|
-1.2%
|
|
MRVL
|
Technology |
Needham |
Maintains
|
Buy
→
Buy
|
—
|
$153.3B
|
$61.34
|
+0.3%
|
+0.9%
|
-1.4%
|
-0.8%
|
-0.1%
|
-1.2%
|
|
AZN
|
Healthcare |
SVB Leerink |
Maintains
|
Outperform
→
Outperform
|
—
|
$146.4B
|
$115.49
|
+4.2%
|
+0.9%
|
-1.4%
|
-1.0%
|
-1.5%
|
+1.6%
|
|
ETN
|
Industrials |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$144.8B
|
$162.81
|
+0.2%
|
-0.6%
|
+0.1%
|
+0.6%
|
+0.2%
|
+2.5%
|
|
ETN
|
Industrials |
Barclays |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$144.8B
|
$162.81
|
+0.2%
|
-0.6%
|
+0.1%
|
+0.6%
|
+0.2%
|
+2.5%
|